Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients-Reference-Cited by-同舟云学术

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients

Published:2018-11-21 Issue: Volume:9 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

Uthman Laween,Baartscheer Antonius,Schumacher Cees A.,Fiolet Jan W. T.,Kuschma Marius C.,Hollmann Markus W.,Coronel Ruben,Weber Nina C.,Zuurbier Coert J.

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference112 articles.

1. Empagliflozin limits myocardial infarction in vivo and cell death in vitro: role of STAT3, mitochondria, and redox aspects.;Andreadou;Front. Physiol.,2017

2. Inflammation determines the pro-adhesive properties of high extracellular D-glucose in human endothelial cells in vitro and rat microvessels in vivo.;Azcutia;PLoS One,2010

3. Chronic inhibition of the Na+/H+-exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling.;Baartscheer;Br. J. Pharmacol.,2008

4. [Na+]I and the driving force of the Na+/Ca2+-exchanger in heart.;Baartscheer;Cardiovasc. Res.

5. Increased Na+/H+-exchange activity is the cause of increased [Na+]I and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model.;Baartscheer;Heart Fail.

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory markers, oxidative stress, and mitochondrial dynamics: Repercussions on coronary artery disease in diabetes;World Journal of Diabetes;2024-09-15

2. Inhibition of the RXRA-PPARα-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model;Science China Life Sciences;2024-08-29

3. SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation;Scientific Reports;2024-07-16

4. Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?;Current Hypertension Reports;2024-06-24

5. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial;Journal of Cardiovascular Development and Disease;2024-06-15